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Abstract 
Background: Myelofibrosis (MF) is characterized by accumulation of stromal cells and 
extracellular matrix. Progression of fibrosis is an important clinical issue and monitoring is 
required for new therapeutic approaches. Currently the quantification is based on semi-
quantitative evaluation of reticulin silver stained slides. We recently reported that platelet 
derived growth factor receptor beta (PDGFRβ) expression in fibroblasts is a useful marker of 
stromal activation. PDGFRβ expression based scores represent significant differences in 
different myelofibrosis grade which provides optimal source of quantification. In this study 
slide based measurements were performed in order to support correlations of PDGFRβ 
expression with MF grade.  
Methods: Scanned image tiles from 79 bone marrow samples (BM) with different 
myelofibrosis grades were evaluated for PDGFRβ-related IHC parameters. Following the 
determination of immunopositive (brown component) and total area (region of interest) of the 
BM, PDGFRβ related image parameters were defined and evaluated in comparison to the 
classical reticulin based grading.  
Results: Eight PDGFRβ expression related image parameters showed excellent correlation 
with the MF grade (correlation coefficient ranging between 0.79 and 0.83) and with PDGFRβ 
score (0.76-0.87). Despite the significant sample heterogeneity the parameters showed 
significant differences between fibrotic and non-fibrotic cases and between mild and 
advanced fibrosis. Distribution of values within a particular specimen emphasizes the 
heterogeneity of bone marrow involvement which may cause difficulties in semi-quantitative 
methods. 
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Conclusions: Our results clearly demonstrated the correlation between myelofibrosis and 
PDGFRβ expression considering all relevant areas in BM samples. This method provides 
good basis for follow-up comparison of the fibrotic samples.  
Keywords: PDGFRβ expression in myelofibrosis, bone marrow biopsy, myeloproliferative 
neoplasia, digital image analysis 
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Introduction 
 
Myelofibrosis (MF) is a disorder of the bone marrow characterized by the 
accumulation of stromal cells and fibrous extracellular matrix which has an adverse effect on 
the hematopoietic activity (8). In the majority of the cases the pathologic mechanism 
including toxic, inflammatory or neoplastic processes is well known. MF usually occurs in 
advanced phases of myelodysplasia and myeloproliferative neoplasia while some clonal 
myeloproliferations are dominated by stromal fibrosis following a prefibrotic phase (primary 
myelofibrosis) (10, 19).  
Classically, the status of the BM and the degree of the fibrotic process is determined 
by histological evaluation in BM trephine biopsies using reticulin silver staining (also named 
as Gomori’s staining) (5). This highlights reticulin and collagen fiber deposition and is 
traditionally applied as a gold standard to determine the MF grade by demonstrating the actual 
amount of stromal fibers produced by stimulated fibroblasts (18).  Accordingly the activation 
and proliferation of non-clonal fibroblasts is an important early event during the generation of 
MF. Fibroblast activity and collagen synthesis is under the control of tissue growth factors, 
such as transforming growth factor beta (TGF-beta) and platelet derived growth factor 
(PDGF) (3, 14). The latter is produced by bone marrow megakaryocytes and stored in the 
alpha granules of platelets to act physiologically as a cytokine mediator and initiator of tissue 
reparation. PDGF receptors (PDGFR) are members of the membrane tyrosine kinase family.  
Homo- or heterodimers are composed of the subunits PDGFRα and PDGFRβ (6, 7). The 
distribution of the PDGF receptor subunits on the surface of different kinds of cells shows 
lineage dependent variability. PDGFRβ acts as a strong activator of fibroblast proliferation 
upon ligand binding (12). As demonstrated by our previous study (2) PDGFRβ subunit was 
expressed by a limited set of mesenchymal cell types in the normal bone marrow. In 
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physiological conditions PDGFRβ positive stromal cells can be detected in the adventitial 
layer of vessel, in the endosteal layer of bone trabecules and further small amounts of 
scattered cells can be found in the intertrabecular bone marrow spaces. The distribution of the 
PDGFRβ positive fibroblasts suggests that these cells are parts of the vascular and 
osteoblastic hematopoietic niche. In bone marrow fibrosis the number of PDGFRβ positive 
cells massively increases. Using an immunohistochemistry based semi-quantitative scoring 
system presented earlier (2), strong correlation could be established between the amount of 
PDGFRβ positive cells (score 0-3) and the grade of myelofibrosis (grade 0-3).   Both the 
PDGFRβ score which represents the number of fibroblasts and the MF grade which highlights 
the amount of the produced fiber show a wide spectrum within the bone marrow. This 
inhomogeneity of the mesenchymal reaction is not reflected properly in semi-quantitative 
methods. 
In the present work we aimed the evaluation of PDGFRβ expression in BM slides 
using image analysis for the accurate and numeric expression of the immunopositivity. To 
evaluate different receptor related image parameters, a recently described image analysis 
algorithm was used (16), which allowed us to define the “region of interest” (intertrabecular 
hematopoietic area) in the complexity of the bone marrow biopsies. Within the region of 
interest the immunopositive areas (brown objects) were defined and characterized by different 
parameter settings.  We assessed the correlation between the PDGFRβ expression related 
image parameters and the conventional MF grade, determined by reticulin silver staining in 
42 bone marrow samples and repeated these analyses in further 37 samples which was not 
included in the initial pilot set of the study. To objectively demonstrate changes in the 
PDGFRβ expression during disease follow-up, serial samples taken from the same patients 
were selected from the latter group for further investigations. 
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Materials and methods 
 
Bone marrow samples 
Altogether seventy-nine trephine biopsy BM samples were selected with different 
degrees of myelofibrosis determined by the classical reticulin silver staining. All bone marrow 
specimens were taken at the Hematology Unit of the University of Debrecen for diagnostic 
purpose.  
A pilot set of 10 non-pathologic and 32 pathologic samples from patients with the 
diagnosis of myeloproliferative neoplasia (14) or myelodysplastic syndrome (18) were 
selected, representing all stages of myelofibrosis. This pilot set was used for method 
development and for the selection of the image parameters. The correlation between PDGFRβ 
related image parameters and established semi-quantitative methods (MF grade and PDGFRβ 
score) and the spatial distribution of the parameters in samples with different MF grades was 
evaluated. To validate this method further 37 bone marrow samples with the diagnosis of 
myeloproliferative neoplasia were selected and evaluated in the same way.  
To objectively demonstrate progressive changes in the PDGFRβ expression in follow-
up cases with myeloproliferative neoplasia, serial bone marrow samples taken from different 
time points from the same patients were selected for further investigation. 
Trephine biopsies were fixed for 24 hours in 4% phosphate buffered formaldehyde and 
decalcified for 48 hours in 1% EDTA. Following tissue processing and paraffin embedding 
4um thick slides were cut for further stainings. 
 
Reticulin silver staining  
 Gomori’s reticulin staining was done according to the routine protocol. Slides were 
incubated in KMnO4 dilution (0,5%), 1-3% solution of potassium metabisulfite, 2% solution 
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of ferric ammonium sulphate for 3 minutes, fresh made solution of silver for 1 minute, 4% 
solution of formalin for 5 minutes, and 0,1-0,2% solution of gold chloride. Every step was 
followed by distilled or tap water flushing. After the silver impregnation slides were 
dehydrated and covered with a cover-glass. The grade of reticulin staining was determined in 
the microscope according to the European Consensus on grading bone marrow fibrosis as 
follows (6). MF-0: faint fragments of reticulin fibers with no intersections; MF-1: loose 
network of elonged reticulin with intersections especially in perivascular areas; MF-2: diffuse 
and dens increase in reticulin with extensive intersections, with occasional bundles of 
collagen; MF-3: diffuse and dens increase in reticulin with extensive intersections, with 
coarse bundles of collagen also associated with apparent osteosclerosis. Evaluation was done 
by two experienced histologists simultaneously using double headed microscope to ensure the 
consistency of scoring. Control cases all showed MF0 grade. 5 of 32 pathological cases were 
classified into the MF0, 13 of 32 into the MF1, 7 of 32 into the MF2 group, while 7 of them 
showed MF3 grade fibrosis. 
 
Immunohistochemistry 
 IHC was done as described earlier (2). To specifically demonstrate PDGFRβ positive 
cells, samples were incubated with anti-PDGFRβ (Abcam, ab-32570) primary monoclonal 
antibody at a dilution of 1:100 for one hour in a wet chamber. Antibody binding was 
visualized by the Dako EnVision FLEX/HRP and FLEX DAB3 Chromogen detection system 
(Dako) which was followed by hematoxylin counterstaining and coverage.  
 The PDGFRβ score was determined in the microscope according to a previously 
proposed scoring system (2). Score 0: no significant amounts of PDGFRβ positive stromal 
cells; score 1: isolated PDGFRβ positive fibroblasts (reticulum cells) present in the 
intertrabecular space; score 2: PDGFRβ positive fibroblasts forming a loose network by 
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partial intersections through long cellular processes; score 3:  bands of PDGFRβ positive 
fibroblasts and their processes with frequent intersections forming a dense network. 
Evaluation was done by two experienced histologists simultaneously using double headed 
microscope to ensure the consistency of scoring. The pathologists were blinded to the results 
of the image analysis. 8 of the 10 control cases all showed PDGFRβ 0 score and 2 of them 
were score 1. 2 of 32 pathological cases were classified into the PDGFRβ 0, 8 of 32 into the 
PDGFRβ 1, 10 of 32 into the PDGFRβ 2 group, while 10 of them showed PDGFR beta 3 
score expression. 
 
 
Image acquisition and analysis 
IHC stained slides were captured by the Pannoramic slide scanner device supplied by 
3DHistech (Budapest, Hungary) using 20x magnification and a multicolor digital camera 
(Stingray F146C IRF Medical, Allied Vision Technologies, Stadtroda, Germany).   
Digitalized images were decompressed to obtain image tiles 768x768 in size which were used 
for evaluation. The total number of analyzed slides in the pilot set (42 cases) was 1437. The 
number of tiles per slide ranged between 6 and 147 (the mean tile number was 40.59) which 
varied according to the size and composition of the biopsy sample. The algorithm for digital 
measurement of PDGFRβ expression was described in detail earlier (16). Briefly, image 
processing was started with the generation of two separated layers (Figure 1.). The first layer 
defined IHC related brown staining or “brown layer” while the rest of the hematoxylin stained 
bone marrow parenchyma was determined as the “violet layer”. The brown layer was 
segmented from the original color images by pixel hue values (hue≤60 and 340≤hue). To 
distinguish the dark brown pixels representing specific antibody related staining in the 
cytoplasm of cells from the light brown pixels (unrelated background staining) background 
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correction was done. To find a suitable threshold we applied the Ramesh method on brown 
pixel saturation (12). The total of brown pixels (Figure 2. b) which had higher saturation as 
the specified threshold was considered as PDGFRβ positive. This purified brown layer 
consisted of brown objects different in size and shape, equivalent with separated or network-
forming immunopositive cells, what was called brown component (Bc). 
The IHC negative parenchyma defined as the violet layer was segmented by hue 
values between 160 and 320, saturation larger than 20.  This did not cover fat tissue as it 
belonged to the white, empty areas of the slide. Besides the immunonegative cells in the 
hematopoietic area, the violet layer contained a lot of unrelated objects, such as bone 
trabecules, blood clots, connective or muscle tissue fragments. The latter unrelated tissue 
components were removed using an automated process. The differences in number and 
distribution of cell nuclei, and in the size of cytoplasm distinguished automatically unrelated 
tissues from hematopoietic areas (16). The violet layer finally contained only those 
immunonegative cells which belonged to the intertrabecular hematopoietic area. This purified 
violet layer was called the violet component (Vc). 
The region of interest was the sum of the Bc and Vc which means that ROI (region of 
interest) consists of immunonegative and immunopositive cells of the intertrabecular spaces 
(Figure 2.). Selection of region of interest was performed automatically without manual 
changes. To validate the automated selection of useful area, ROI was selected in 419 tiles 
manually (300 randomly selected tiles, and 119 potentially problematic tiles) by an 
experienced pathologist and by the automated process as well. The specificity of the 
automated selection proved to be 97%. In order to characterize the IHC staining in each 
sample Bc and ROI were evaluated for a set of image parameters (Table 1.). The following 
parameters were evaluated in detail each tile.  Number of objects: the total number of 
intertrabecular brown (immunopositive) objects which consist of PDGFRβ positive cells. 
Page 9 of 31
John Wiley and Sons, Inc.
Cytometry: Part B - Clinical Cytometry
10 
 
SumArea: the sum of the area (pixels) of all brown objects. SumPerimeter: the sum of the 
perimeter of all brown objects. (15). Further, we also considered the complexity of the brown 
objects by calculating the skeleton. SumSkeleton: the sum of the skeleton of all brown objects 
.The skeleton is the locus of the centers of all maximal inscribed hyper-spheres (i.e., discs and 
balls in 2D and 3D, respectively). An inscribed hyper-sphere is maximal if it is not covered by 
any other inscribed hyper-sphere (4). An additional parameter was the weighted Perimeter 
where the number of cross-points and end-points within the objects were considered 
(wPerimeter).  The more complex network could be expected, the higher wPerimeter was 
calculated, even if the sumPerimeter itself was not increased due to the attachment of smaller 
objects. 
Digital measurements resulted in representative numeric values reflecting individual 
specific features of the PDGFRβ staining pattern in each actual tile as a separated feature. 
Besides the total values (Sum), their highest fifty derivates (Top50 values) were also 
calculated for each tile of a case. In addition Top50 values were assessed for the whole slide 
as well. Relevant parameters were also normalized with the total intertrabecular marrow 
parenchyma (ROI).  
Altogether 13 parameters were defined: SumArea, SumPerimeter, SumSkeleton, 
Number of objects, SumArea/ROI, SumPerimeter/ROI, SumSkeleton/ROI, Number of 
objects/ROI, Top50Area, Top50Perimeter, Top50Skeleton, Number of objects/Bc, 
wPerimeter/ROI. 
Data from all image tiles were collected automatically without any manual changes. 
Before statistical analyses outlier values were removed. Altogether 13 parameters were 
evaluated, and only 2.5% of all tiles contained one or more outlier parameters. Outliers 
appeared mostly in cases with low amount PDGFRβ positive cells. Here, normal bone 
marrow vessels with immunopositive adventitial layer presenting as huge brown objects occur 
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in addition to the small scattered brown objects representing individual fibroblasts. Statistical 
analyses were performed before and after the exclusion of outliers and very similar results 
were obtained. Although the outliers did not significantly influence the results with the 
current set of cases, the exclusion of them may be important when we focus exclusively on a 
collection of pre-fibrotic bone marrow. 
 
Statistical evaluation 
Statistical evaluation and graphs were made using the GraphPad Prism software. 
Correlation between image parameters and classical MF grades was evaluated in detail. The 
Pearson r was calculated with 95% confidence interval, p<0.05 was considered to be a 
significant correlation, r > 0.75 was considered as strong correlation.  
 
Results 
 
Image processing and validation of PDGFRβ related measurements 
 Bone marrow biopsy specimens were captured using a slide scanner and the 
digitalized slides were decompressed into tiles with a uniform size of 768x768 pixels. These 
images covering the whole slides were applicable for a tile by tile image analysis process. 
PDGFRβ related immunopositivity could be clearly represented in tiles of digitalized 
bone marrow slides independent from the cellular composition of the parenchyma (Figure 2.). 
A tile by tile quantitative analysis was performed for both the Brown component (Bc) and the 
region of interest (Bc + Vc) in separated image layers created on the basis of the color hue 
scales. Altogether 13 parameters were analyzed in digital slides and all of them showed 
significant correlation with the grade of MF and the PDGFRβ score. Eight of them showed 
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strong correlation (r>0.75) with the microscopic MF grade and PDGFRβ score as well 
(r>0.75) (Table 2.). These eight parameters were further assessed. 
Image processing and statistical analyses were repeated in further 37 samples not 
included in the pilot set for validation purposes. Significant correlation of the eight image 
analysis parameters with MF grade and PDGFRβ score could be clearly validated. Spearman r 
ranged between 0.72 and 0.81 for MF grade and between 0.70 and 0.85 for PDGFRβ score. 
 
PDGFRβ image parameters correlation with MF grade 
Marked differences were identified in the different MF subgroups defined by the 
classical semi-quantitative method.  To evaluate differences characteristic for MF grades, 
image parameters calculated for the whole slides were statistically analyzed (Figure 3). As 
expected, there was no measurable difference between the normal control BM and pathologic 
BM lacking fibrosis (MF0). In contrast, a gradual increase in all evaluated data sets could be 
seen from the MF0 to the MF3 grades in the diseased bone marrow.  All of the eight selected 
parameters showed significant difference between MF0 and MF1 grades (P values between 
0.012 and 0.047); M0 and MF2 grades (p<0.0001 in all settings); and MF0 and MF3 grades 
(p<0.0001 in all settings). All parameters of MF1 (mild fibrosis) vs. MF2 (intermediate 
reticulin fibrosis) cases showed robust differences with high significance levels 
(Top50Skeleton p=0.0012; Top50Perimeter p=0.0011; Top50Area p=0.0015; 
SumSkeleton/ROI p=0.0006; SumPerimeter/ROI p=0.0001; wPerimeter/ROI p=0.0149; 
SumArea/ROI p<0.0001; Number of objects/Bc p<0.0001). However, none of the applied 
parameters resulted in a statistically significant differences between pathologic MF2 and 
pathologic MF3 grades representing advanced fibrosis (Figure 3.).  
There was no significant difference in the mean grade of myelofibrosis between the 
two pathological subgroups (MDS 1.60 vs. MPN 1.56 p=0.9322). None of the eight selected 
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PDGFR β related image parameters showed significant difference between these categories (P 
values between 0.2914 and 0.9957). 
 
Comparison and graphical presentation of PDGFRβ expression in follow-up cases 
using immunohistochemistry based image analysis 
 
The grade of myelofibrosis may vary remarkably within the bone marrow as regions 
around megakaryocyte clusters, perivascular and paratrabecular areas are usually more 
severely affected. PDGFRβ expression shows wide heterogeneity as well. Figure 4. shows 
results of measurements from 42 analyzed slides (n=1437 tiles) to demonstrate the continuous 
spectrum of values and the overlap between different MF subgroups for just two selected 
parameters (x= SumArea/ROI and y= Top50Area). Both parameters represent the area of 
immunopositive objects. Similarly wide distribution could be seen with the combination of 
those parameters which reflect the perimeter or the skeleton of immunopositive objects 
(diagrams not shown). 
To see the utility of tile-based parameter measurement, serial follow-up bone marrow samples 
(not included in the pilot set of this study) were digitalized and analyzed from selected cases. 
Four parameters evaluated for objective sample comparison (SumArea/ROI; Number of 
objects/SumArea; Top 50 Area; Sum Perimeter/ROI) nicely reflected the dynamic of the 
fibrotic process.  Figure 5. shows two examples for high-performance follow-up evaluation of 
bone marrow samples from patients with myeloproliferative neoplasia. In the first case the 
primary biopsy did not show fiber accumulation (MF grade 0), although a mild fibroblast 
activation was detected using PDGFRβ staining (PDGFRβ score 1). The follow up biopsy 12 
months later presented advanced fibrosis (MF grade 2) and extended fibroblast proliferation 
(PDGFRβ score 2). There was a significant difference between the primary and follow-up 
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samples for all measured image parameters (p<0.0001) (Figure 5a). A second case presented 
with advanced fibrosis at the time of diagnosis (MF grade 2) which was accompanied by 
remarkable fibroblast accumulation as expected (PDGFRβ score 2). 4 years later, the follow 
up biopsy reflected that the fibrosis became more extended (MF grade 3), and so did the 
fibroblast accumulation (PDGFRβ score 3). Although tile based parameter values from the 
two samples were partially overlapping due to tissue heterogeneity, statistical analysis 
revealed significant differences in all of the four parameter combinations (p<0.0001) Figure 
5b.. 
 
 
Discussion 
 
PDGFRβ was described as a marker of activated mesenchymal cells, predominantly 
fibroblasts and was reported to have significant regulatory role in experimental fibrotizing 
conditions e.g. lung and liver fibrosis (1, 9, 11, 12). PDGFRβ expressing activated fibroblasts 
are responsible for matrix fiber production and therefore, their exact demonstration may 
provide insight into the dynamics of stromal reaction. Increase in PDGFRβ expression in the 
bone marrow related with the number of activated fibroblasts which correlated tightly with the 
grade of reticulin fibrosis using a semi quantitative four grade (0-3) microscopic scoring 
system (Spearman r =0.83; p<0.0001; n=60) (2). The proposed system – similar to the widely 
used reticulin evaluation scheme – considers mainly the mass and the complexity of the 
positive objects forming an increasing network in the progressive disease. Our result could be 
reproduced with the current measurements (Spearman r =0.84; p<0.0001; n=79), although the 
cases of the two studies showed partial overlap (23 cases were involved in both studies). 
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Although attempts for the automated assessment of reticulin fibrosis and osteosclerosis 
have been previously published showing good correlation with the semi-quantitative grading 
methods (17), these did not gain broad acceptance. In this study we describe a novel approach 
based on PDGFRβ immunohistochemistry and digitalized slide measurements. Tile-by-tile 
image analysis on scanned bone marrow sections strongly supported our earlier findings (2). 
To address PDGFRβ immunopositivity in digitalized slides several adjustments had to be 
performed. Bone marrow biopsy specimens very frequently contain other tissue elements such 
as fat, bone, skeletal muscle and connective tissue. To assess the extent and complexity of 
immunopositivity it was important to focus only the relevant intertrabecular spaces where 
hematopoiesis occurs. A major achievement of the presented analysis tool was the automated 
selection of the relevant measurement region (ROI) done by an algorithm carefully tested in a 
pilot setting.  
The complexity of the immunopositive network formed by PDGFRβ expressing 
fibroblasts was addressed by the evaluation of a larger set of relevant image parameters. 
Related parameter values were established following the selection of relevant brown pixels 
for each tile. Area, number, perimeter, weighted perimeter and skeleton of brown objects were 
calculated) in each tiles. Total values (sum), derivates (top50 parameters) and normalized 
values (/ROI or /Bc) were calculated to qualify individual cases.  
Area reflected mostly the actual mass of positive fibroblasts. The more positive cells 
presented the bigger was the area irrespective of the distribution of the cells. Perimeter and 
skeleton values addressed much more the overall distribution of the staining representing the 
varying density of cells and the increase in cell-to-cell connections characteristic for more 
advanced stage of fibrosis. These parameters can hypothetically reach a plateau level in 
advanced fibrosis when PDGFRβ positive cells form large, nearly homogenous areas. A 
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similar phenomenon is expected when the number of positive objects (activated fibroblasts) 
drops in late fibrosis.   
Area, perimeter and skeleton values of brown objects are all supposed to be influenced 
by heterogeneity within the bone marrow parenchyma, therefore the total values of the 
individual tiles were calculated. Accordingly, significant correlation with the MF grade could 
be stated at the whole slide level (Table 2). Variety in sample size and cellularity made the 
normalization with the total intertrabecular hematopoietic area (ROI) necessary (Table 2). As 
the ROI did not include the fat tissue, values after normalization wit ROI were not further 
influenced by the cellularity. MF is characterized by the gradual increase of stromal cell mass 
starting from isolated mesenchymal cells. Even in advanced fibrosis with complex networks, 
scattered individual fibroblasts not communicating with the network are expected to be 
present. As this large number of brown objects with small area, perimeter, and skeleton may 
potentially cover features of progression, the highest 50 (Top 50) values of area, perimeter 
and skeleton were also considered. As a result, Top 50 parameter values demonstrated highly 
significant and strong differences between the MF grades.  
Using the above mentioned PDGFRβ related image parameters we were able to 
demonstrate significant differences between individual MF grades. All of the 13 analyzed 
parameters were in correlation with the MF grade. Eight parameters (SumArea/ROI, 
SumPerimeter/ROI, SumSkeleton/ROI, wPerimeter/ROI, Top50Area, Top50Perimeter, 
Top50Skeleton, Number of objects/Bc) showed strong correlation (Spearman r>0.75) with 
MF grade and PDGFRβ score as well. We were able to validate significant correlation in a 
second set of bone marrow samples with 37 specimens stained for PDGFRβ. SumArea, 
SumPerimeter, SumSkeleton, Number of objects, Number of objects/ROI were in weak 
correlation with MF grade in initial testing so they were dropped.  
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On the basis of our studies, selected PDGFRβ related image parameters proved to be 
effective to distinguish bone marrow samples with myelofibrosis from the non-fibrotic group 
(all of the eight parameters in Table 2. comparing MF0 to M1-3) or to differentiate between 
mild and advanced fibrosis (all of eight parameters in Table 2. comparing MF1 to MF 2). 
Especially SumArea/ROI; Number of objects/Bc, SumPerimeter/ROI and SumSkeleton/ROI 
were applicable (p value ranges between <0.0001 and 0.0006). However, none of the applied 
image parameters represented clear differences between pathologic MF2 and pathologic MF3 
grades (advanced fibrosis). It has to be mentioned that MF grades reflect the mass of fibers 
produced by fibroblasts, while PDGFRβ related parameters indicate the amount of newly 
generated fibroblast.  It can be speculated that fibroblast activation and proliferation precedes 
fiber production in early lesions. In reverse, activated fibroblast highlighted by PDGFRβ may 
not be proportionally required in end-stage disease.  
In the most advanced phase of myelofibrosis, PDGFRβ positive fibroblasts form a 
dense network which could be associated with the maximal grade of fibrosis if the process is 
fully developed.  In our study only 6 of the 10 cases with PDGFRβ score 3 showed the most 
extended fiber accumulation (MF-3). In other cases the fibroblast accumulation reached a 
maximum level (PDGFRβ score 3) while the fiber accumulation was still in progress and the 
sample was classified as MF2 (3 cases) or MF1 (1 case).  
Bone marrow heterogeneity is well known in myelofibrosis. The bone marrow 
parenchyma is not uniformly involved by the distribution of activated fibroblasts and 
extracellular matrix fibers. The classical MF grading is mainly based on the dominant changes 
occurring in the section while image measurements (depending on the parameters selected) 
more reflect the mean of all events irrespective of their distribution. From this perspective, it 
may be difficult to identify finer differences during follow-up studies using a four grade semi-
quantitative system. The clinical need to assess the status of stromal activation more precisely 
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during patient follow-up is clear. Moreover, PDGFRβ based image analysis could be an 
objective tool to evaluate the therapeutic efficiency of new treatment protocols including e.g. 
JAK-2 inhibitors.  Figure 5. demonstrates application on follow-up samples, where each dot 
represents parameters from a single tile. Although tile-based image parameter values showed 
a high variability within and an overlap between the serial samples, statistical calculations 
pointed to significant differences. The presented follow up cases give typical examples for the 
heterogeneous composition of bone marrow samples.   
Although some of PDGFRβ related image parameters showed excellent correlation 
with the MF grade, mesenchymal activation related PDGFRβ expression was more extended 
then fiber accumulation in different MF subgroups. As fibroblast proliferation precedes fiber 
production, it can be hypothesized, that elevated PDGFRβ expression is useful for the 
prediction of MF progression. This issue can be especially interesting in pre-fibrotic cases or 
in cases with mild fibrosis, but it requires a statistical evaluation of a larger sample cohort. 
The PDGFRβ expression related image analysis is a promising example for digital 
support of the evaluation of immunohistochemical reactions. Besides the appropriate selection 
of intertrabecular hematopoietic area in the complex bone marrow, the analysis of well 
defined parameters describing networks with different extension is also enabled. Based on the 
statistical analyzes eight parameters showed strong correlation with the semi-quantitative 
methods (SumArea/ROI, SumPerimeter/ROI, SumSkeleton/ROI, wPerimeter/ROI, 
Top50Area, Top50Perimeter, Top50Skeleton, Number of objects/Bc). As skeleton and 
perimeter provide similar information about the extension of the network, and the statistical 
analyzes could not reveal differences between them, it is not necessary to use both parameters 
for the same time. Finally, a combination of five parameters (SumArea/ROI, 
SumPerimeter/ROI, Top50Area, Top50Perimeter, Number of objects/Bc) can be proposed for 
the digital image analysis of bone marrow samples stained for PDGFRβ. We believe that 
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parameters introduced here are able to precisely characterize the extent and complexity of 
immunopositive objects. As such, this approach could also be used for similar 
immunostainings highlighting network-forming elements, e.g. stroma cells positive for 
tenascin. 
 In conclusion, PDGFRβ was found to be a practically useful stromal activation 
marker, also enabling automatic image analysis. Digital tile based evaluation of PDGFRβ 
immunostaining reflected significant differences in stromal activity and demonstrated 
intraparenchymal heterogeneity in different hematopathological conditions of the bone 
marrow. 
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Table and figure legends 
Table 1. Definitions of image parameters applied to describe PDGFRβ related 
immunopositive areas captured from digital slides.  
* Relevant parameters were also used normalized with the total marrow parenchyma (region 
of interest, /ROI). 
 
Table 2. Correlation of image parameters representing PDGFRβ immunopositivity in scanned 
digital sections with myelofibrosis grade and PDGFRβ score determined by classical 
microscopy. PDGFRβ (Brown component = Bc) related parameters were ranked according to 
the correlation coefficients. Strong correlation was stated for the eight listed parameters 
(r>0.75).  
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Figure 1.  Image analysis algorithm for the evaluation of platelet derived growth factor 
receptor beta (PDGFRβ) expression in digitalized bone marrow biopsy specimens.  
 
Figure 2. Digital captures of PDGFRβ immunostained bone marrow samples 
representing a strong positivity in an MF2 case.  A: Unprocessed digital image tile 
representing remarkable PDGFRβ expression in true colors. B: Segmentation of brown layer 
after background correction resulted in the PDGFRβ related brown component (Bc) which is 
the sum of high saturated brown pixels. Brown objects appear in different size. C: 
Segmentation of violet layer after automated removal of unrelated structures (bone trabecules) 
which results in purified violet layer called the violet component (Vc). D: The region of 
interest (ROI) was calculated (Bc + Vc) containing all relevant components of the cellular 
bone marrow parenchyma.  
 
Figure 3. Mean values of PDGFRβ related image parameters in different grades of 
myelofibrosis (n=42). MF grade (0-3) was conventionally determined in the microscope 
following classical reticulin staining in normal (control) bone marrows and in different 
pathologic conditions associated with marrow fibrosis. MF0 path represent cases with 
established histopathological diagnosis lacking considerable amounts of myelofibrosis, 
potentially including prefibrotic bone marrows. (MF: myelofibrosis) 
 
Figure 4. Distribution of SumArea/ROI and Top50 Area values in the total collection of 
tiles (n= 1437) measured in 42 slides. Specific MF grades are highlighted by dark dots while 
all tiles are represented in the background. Samples with different MF grades were impossible 
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to separate due to significant tissue heterogeneity but the gradual increase was obvious in 
accordance with PDGFRβ expression. 
 
Figure 5. Follow-up analysis of bone marrow samples from sequential biopsies with 
progressive myeloproliferative neoplasia. Each dot represents values from a single tile, the 
follow up samples are indicated by different dot marking (blue = first biopsy, red = second 
biopsy). 
Case 1 (left). Mild fibroblast activation (first biopsy, MF-0, PDGFRβ score 1) progressed to 
marked accumulation of stromal cells in the follow-up biopsy (second biopsy, MF-2, 
PDGFRβ score 2) which was clearly shown by significant changes of PDGFRβ related image 
parameters. The partial overlap between the tiles of the two samples can be explained by the 
uneven distribution of the fibrotic change within the bone marrow sample. Statistically 
significant difference could be revealed for all parameters. 
Case 2 (right). Advanced fibrosis could be detected already at the time of histological 
diagnosis (first biopsy, MF-2, PDGFRβ score 2) which became more severe in a sample 
obtained 4 years later (second biopsy, MF-3, PDGFRβ score 3). Statistically significant 
difference could be revealed for all parameters between the initial and the follow up samples. 
ROI: region of interest (Brown component + Violet component). 
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Table 1. 
Parameter * Definition 
Number of objects  Number of immunopositive (brown) objects 
SumArea Sum of immunopositive pixels in all objects 
SumSkeleton Sum of the distance of skeletons calculated in immunopositive objects 
SumPerimeter Sum of immunopositive object perimeters 
WPerimeter Sum of immunopositive objects weighted perimeters (with the number 
of cross-points and endpoints) 
  
Top 50 Area Sum of pixels of the 50 immunopositive objects with the largest area 
Top 50 Skeleton Sum of the distances of 50 immunopositive objects with the largest 
skeleton distance 
Top 50 Perimeter Sum of the 50 immunopositive object with largest perimeters 
/ROI parameters normalized with the region of interest 
/Bc parameters normalized with the brown component 
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Table 2. 
Parameter  Correlation with MF grade  Correlation with PDGFRβ score  
Spearman-R  P-value  Spearman-R  P-value  
PDGFRβ score    0,8578    < 0,0001  -  -  
MF grade  -  -    0,8578  < 0,0001  
SumArea/ROI    0,7956    < 0,0001    0,8669    < 0,0001  
Number of objects/Bc    -0,7893    < 0,0001    -0,7594    < 0,0001  
Sum Perimeter/ROI    0,7886    < 0,0001    0,8702    < 0,0001  
wPerimeter/ROI    0,8233    < 0,0001    0,8473    < 0,0001  
Sum Skeleton/ROI    0,7878    < 0,0001    0,8650    < 0,0001  
Top 50 Area    0,8093    < 0,0001    0,7626    < 0,0001  
Top 50 Perimeter    0,8237    < 0,0001    0,7898    < 0,0001  
Top 50 Skeleton    0,8279    < 0,0001    0,7860    < 0,0001  
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Figure 2.c.          Figure 2.d. 
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Figure 4. 
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